Connecting Data to Contextualize the Complex Diabetes Journey
Diabetes is a complex disease that affects over 37 million Americans, or 11% of the population, and...
A better way to measure healthcare costs in closed claims data This is the second post in our four-part taXonomy X blog series (part 1 here), and here we’ll discuss one of the most common pain points in closed claims analytics: costs. Specifically,...
Diabetes is a complex disease that affects over 37 million Americans, or 11% of the population, and...
As we honor our military service members this Veterans Day, we take time to reflect on how we can...
In a recent report, the Centers for Disease Control and Prevention (CDC) found that four out of...
Author: Emery Niemiec, Director, Partners & Alliance at HealthVerity Privacy preserving record...
HealthVerity’s journey from an unknown startup to a major disrupter in the Healthcare industry ...
The Inside Story Behind MOM, the Maternal Outcomes Masterset In the Spring of 2021, HealthVerity...
Written by Emery Niemiec I recently attended the 2022 INFORMS Business Analytics Conference and had...
Exploring the impacts and benefits of a real-world data strategy for long-term care insurance...
Why government and public health agencies contract for the HealthVerity IPGE platform as a trusted...
In the first installment of our HealthVerity IPGE blog series covering the four foundational...
In epidemiology, statistical power determines whether a study can accurately detect an effect of a given size with a specified probability, typically 80% or higher. When studies fall below that threshold, the consequences extend well beyond inconclus...